1. Home
  2. ORIC vs USNA Comparison

ORIC vs USNA Comparison

Compare ORIC & USNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ORIC
  • USNA
  • Stock Information
  • Founded
  • ORIC 2014
  • USNA 1992
  • Country
  • ORIC United States
  • USNA United States
  • Employees
  • ORIC N/A
  • USNA N/A
  • Industry
  • ORIC Biotechnology: Pharmaceutical Preparations
  • USNA Medicinal Chemicals and Botanical Products
  • Sector
  • ORIC Health Care
  • USNA Health Care
  • Exchange
  • ORIC Nasdaq
  • USNA Nasdaq
  • Market Cap
  • ORIC 362.9M
  • USNA 565.2M
  • IPO Year
  • ORIC 2020
  • USNA 1996
  • Fundamental
  • Price
  • ORIC $11.10
  • USNA $32.95
  • Analyst Decision
  • ORIC Strong Buy
  • USNA Hold
  • Analyst Count
  • ORIC 9
  • USNA 1
  • Target Price
  • ORIC $18.29
  • USNA $36.00
  • AVG Volume (30 Days)
  • ORIC 949.2K
  • USNA 149.7K
  • Earning Date
  • ORIC 08-11-2025
  • USNA 07-22-2025
  • Dividend Yield
  • ORIC N/A
  • USNA N/A
  • EPS Growth
  • ORIC N/A
  • USNA N/A
  • EPS
  • ORIC N/A
  • USNA 1.82
  • Revenue
  • ORIC N/A
  • USNA $876,242,000.00
  • Revenue This Year
  • ORIC N/A
  • USNA $13.04
  • Revenue Next Year
  • ORIC N/A
  • USNA $7.36
  • P/E Ratio
  • ORIC N/A
  • USNA $18.09
  • Revenue Growth
  • ORIC N/A
  • USNA N/A
  • 52 Week Low
  • ORIC $3.90
  • USNA $23.10
  • 52 Week High
  • ORIC $14.67
  • USNA $48.85
  • Technical
  • Relative Strength Index (RSI)
  • ORIC 66.82
  • USNA 63.95
  • Support Level
  • ORIC $10.42
  • USNA $32.01
  • Resistance Level
  • ORIC $11.50
  • USNA $33.95
  • Average True Range (ATR)
  • ORIC 0.62
  • USNA 0.87
  • MACD
  • ORIC -0.03
  • USNA 0.15
  • Stochastic Oscillator
  • ORIC 83.30
  • USNA 76.58

About ORIC Oric Pharmaceuticals Inc.

ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.

About USNA USANA Health Sciences Inc.

Usana Health Sciences Inc is a direct selling and direct-to-consumer nutrition, personal health and wellness company. It developed and manufactured science-based nutritional, personal care and skincare products with a focus on promoting long-term health and wellness. The company has two reportable segments: direct selling and Hiya direct-to-consumer. The direct selling segment develops and manufactures high quality, science-based nutritional, personal care and skincare products with a focus on promoting long-term health and wellness in various geographic markets that are distributed through the direct selling channel. The Hiya direct-to-consumer segment is a provider of children's health and wellness products in the U.S. Key revenue is generated from Direct selling segment.

Share on Social Networks: